125 related articles for article (PubMed ID: 38729224)
21. Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria.
Li Q; Lugt CB; Looareesuwan S; Krudsood S; Wilairatana P; Vannaphan S; Chalearmrult K; Milhous WK
Am J Trop Med Hyg; 2004 Dec; 71(6):723-31. PubMed ID: 15642961
[TBL] [Abstract][Full Text] [Related]
22. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
Margolis DA; Gonzalez-Garcia J; Stellbrink HJ; Eron JJ; Yazdanpanah Y; Podzamczer D; Lutz T; Angel JB; Richmond GJ; Clotet B; Gutierrez F; Sloan L; Clair MS; Murray M; Ford SL; Mrus J; Patel P; Crauwels H; Griffith SK; Sutton KC; Dorey D; Smith KY; Williams PE; Spreen WR
Lancet; 2017 Sep; 390(10101):1499-1510. PubMed ID: 28750935
[TBL] [Abstract][Full Text] [Related]
23. 3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
Pou S; Winter RW; Dodean RA; Liebman K; Li Y; Mather MW; Nepal B; Nilsen A; Handford MJ; Riscoe TM; Laxson S; Kirtley PJ; Aleshnick M; Zakharov LN; Kelly JX; Smilkstein MJ; Wilder BK; Kortagere S; Vaidya AB; Alday PH; Doggett JS; Riscoe MK
ACS Infect Dis; 2024 Jun; ():. PubMed ID: 38862127
[TBL] [Abstract][Full Text] [Related]
24. Malaria Surveillance - United States, 2016.
Mace KE; Arguin PM; Lucchi NW; Tan KR
MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
[TBL] [Abstract][Full Text] [Related]
25. Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia.
Robinson DG; Suett M; Wilhelm A; Chaijale N; Franzenburg KR; Gandhi S; Cloud B; Mychaskiw M
Adv Ther; 2023 May; 40(5):2249-2264. PubMed ID: 36905498
[TBL] [Abstract][Full Text] [Related]
26. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz RJ; Li S; Grinsztejn B; Dawood H; Liu AY; Magnus M; Hosseinipour MC; Panchia R; Cottle L; Chau G; Richardson P; Marzinke MA; Hendrix CW; Eshleman SH; Zhang Y; Tolley E; Sugarman J; Kofron R; Adeyeye A; Burns D; Rinehart AR; Margolis D; Spreen WR; Cohen MS; McCauley M; Eron JJ
PLoS Med; 2018 Nov; 15(11):e1002690. PubMed ID: 30408115
[TBL] [Abstract][Full Text] [Related]
27. A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection.
Thing M; Ågårdh L; Larsen S; Rasmussen R; Pallesen J; Mertz N; Kristensen J; Hansen M; Østergaard J; Larsen CS
J Pharm Sci; 2014 Dec; 103(12):4021-4029. PubMed ID: 25354787
[TBL] [Abstract][Full Text] [Related]
28. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
[TBL] [Abstract][Full Text] [Related]
29. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.
Wattanakul T; Teerapong P; Plewes K; Newton PN; Chierakul W; Silamut K; Chotivanich K; Ruengweerayut R; White NJ; Dondorp AM; Tarning J
Malar J; 2016 Apr; 15():244. PubMed ID: 27118212
[TBL] [Abstract][Full Text] [Related]
31. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
[TBL] [Abstract][Full Text] [Related]
32. Lipid based intramuscular long-acting injectables: Current state of the art.
Wilkinson J; Ajulo D; Tamburrini V; Gall GL; Kimpe K; Holm R; Belton P; Qi S
Eur J Pharm Sci; 2022 Nov; 178():106253. PubMed ID: 35793750
[TBL] [Abstract][Full Text] [Related]
33. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
Banting AL; Baggot JD
J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
[TBL] [Abstract][Full Text] [Related]
35. Severe embryolethality of artesunate related to pharmacokinetics following intravenous and intramuscular doses in pregnant rats.
Li Q; Si Y; Xie L; Zhang J; Weina P
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):385-93. PubMed ID: 19851989
[TBL] [Abstract][Full Text] [Related]
36. Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: In vitro and in vivo evaluation.
Elbrink K; Van Hees S; Chamanza R; Roelant D; Loomans T; Holm R; Kiekens F
Eur J Pharm Biopharm; 2021 Jun; 163():158-170. PubMed ID: 33848628
[TBL] [Abstract][Full Text] [Related]
37. Prodrugs of bisthiazolium salts are orally potent antimalarials.
Vial HJ; Wein S; Farenc C; Kocken C; Nicolas O; Ancelin ML; Bressolle F; Thomas A; Calas M
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15458-63. PubMed ID: 15492221
[TBL] [Abstract][Full Text] [Related]
38. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.
Charman SA; Arbe-Barnes S; Bathurst IC; Brun R; Campbell M; Charman WN; Chiu FC; Chollet J; Craft JC; Creek DJ; Dong Y; Matile H; Maurer M; Morizzi J; Nguyen T; Papastogiannidis P; Scheurer C; Shackleford DM; Sriraghavan K; Stingelin L; Tang Y; Urwyler H; Wang X; White KL; Wittlin S; Zhou L; Vennerstrom JL
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4400-5. PubMed ID: 21300861
[TBL] [Abstract][Full Text] [Related]
39. Clinical review of a long-acting, injectable formulation of risperidone.
Knox ED; Stimmel GL
Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
